• Investment World
• eWorld
• Brand Line
• Mentor
• Life
• Canvas
• Praxis
• Urban Pulse
• Brand Quest
• The New Manager

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Cross Currency

• Rates
  
  

Shipping

• Ports
  
  

Archives

• Yesterday
• Datewise
• Resources
• In Focus
• In Depth

Group Sites

• The Hindu
• The Hindu ePaper
• Business Line
• Business Line ePaper
• Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Our Bureau

NEW FACILITY: Mr Kapil Sibal, Union Minister for Science and Technology, with Mr Shyam S. Bhartia, Chairman and Managing Director, Jubilant Organosys Ltd, and Mr Harish S. Bhartia, the company's Co-chairman and Managing Director, during the inauguration of the firm's drug discovery facility in Bangalore on Saturday. — G.R.N. Somashekar

Bangalore , Nov. 25

The Ministry for Science and Technology is putting finishing touches to a draft legislation that would reward the entire scientific pool of the country.

"A bill (expected to be passed in the Budget session) that looks at incentivising the scientific community to create intellectual property (IP) is being prepared," the Union Minister for Science and Technology and Earth Sciences, Mr Kapil Sibal, told media persons here on Saturday.

Speaking at the inauguration of Jubilant Organosys' drug discovery facility, Mr Sibal spoke of the need to create the necessary human resources base in the country that would cater to the R&D needs of the world.

The legislation would emphasise on the reporting requirement of IP by scientists. About one-third of the royalty realised from the patent creation would be paid to the scientists creating the IP, one-third would be ploughed back into the project and one-third to the research institute.

Jubilant's drug discovery centre would focus on collaborative development of novel molecules that have potential therapeutic use to treat diseases in the areas of cancer, diabetes, obesity, cardio-vascular diseases, tuberculosis and HIV. The focus would be on collaborative research with the company's customers globally, said Mr Shyam Bhartia, Chairman and Managing Director, Jubilant Organosys.

Set up with an initial investment of Rs 70 crore, the 1.25-lakh sq ft facility houses around 500 scientists working in the areas of molecular modelling, protein crystallography, medicinal chemistry and invitro/invivo capabilities.

More Stories on : Science & Technology | People | Policy

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
India Inc heads to south Russia

Copyright © 2006, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line